events

HUM-MOLGEN -> Events -> Meetings and Conferences

Search

Microbiome Discovery & Development Congress

November 16, 2016

Oxford Global, Hotel Palace, Berlin, Germany 12 - 13 June 2017 Oxford Global is proud to present the Microbiome Discovery and Development Congress taking place on the 12th & 13th June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends. In recent years, there has been a substantial growth in interest in the microbiome. As of yet, no drugs have been approved, however with numerous therapeutics in clinical development the microbiome is set to revolutionise disease therapeutics, diagnostics and preventative medicine. The emerging microbiome market is expected to reach US$658 million by 2023. Our programme covers the hottest topics in microbiome research, articulating the challenges of the field and considering the latest research trends. Not-to-be-missed sessions include: Europe First, USA Second: Greg Sieczkiewicz, MPM Capital, will discuss the IP considerations of commercialising the microbiome Dirk Gevers, Global Head of the Janssen Human Microbiome Institute, will present an pharma perspective on this burgeoning industry Johan van Hylckama Vlieg, VP, Chr-Hansen, covers how best to amplify live bacterial Francois-Pierre Martin, Senior Scientist, Nestle Institute of Life Science, will share his work on small molecule microbial drug discovery Further sessions focus on the therapeutic potential of the microbiome, with exciting new biotech companies presenting their early work on developing novel therapeutics. Studies of the Gut Microbiome have dominated research and clinical studies, focussing particularly on C. difficle and inflammatory conditions. Interest is growing, however, in other areas of microbiome research, and the latest trends in Dermatology and Women's Health will also be presented. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. It follows on from the success of its co-located events: our highly anticipated 18th Drug Discovery Summit and 5th Discovery Chemistry & Drug Design Congress, which bring together over 250 key opinion leads and senior industry experts in drug discovery.

Organized by:			Oxford Global
Invited Speakers:			Confirmed Speakers Include: - Johan van Hylckama Vlieg, VP Microbiome and Health Innovation, Chr-Hansen A/S - Dirk Gevers, Global Head, Janssen Human Microbiome Institute, Janssen - Luc Sterkman, CEO, Caelus Health - Jean de Gunzburg, CSO, Da Volterra - Herve Affagard, CEO, MaaT Pharma - Greg Sieczkiewicz, Managing Director and Chief IP Counsel, MPM Capital - Adam Baker, Head of Discovery - Microbiome and Human Health, Chr-Hansen A/S - Sonia Timberlake, Director of Data Science, Finch Therapeutics - Francois-Pierre Martin, Senior Scientist, Nestle Institute of Health Sciences - Tom van de Wiele, Associate Professor, Host-Microbe Interaction Technology Group, Ghent University - Adrien Nivoliez, Director of R&D and Business Development, Biose

Deadline for Abstracts:			N/A

Registration:			For further information about registration please contact marketing@oxfordglobal.co.uk or phone +44 (0) 1865 248455

events

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.